Literature DB >> 17981728

HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis.

Marcus Kaul1.   

Abstract

Infection with the human immunodeficiency virus-1 (HIV-1) and acquired immunodeficiency syndrome (AIDS) are often associated with severe and debilitating neurological problems that include behavioral abnormalities, motor dysfunction and frank dementia. HIV-1-infected peripheral immune cells, in particular macrophages, appear to infiltrate the CNS, release neurotoxins and provoke a neuropathological response involving all cell types in the brain. In the CNS, HIV-1 and its components initiate activation of chemokine receptors, inflammatory mediators and glutamate receptor-mediated excitotoxicity, all of which can activate numerous downstream signaling pathways and disturb neuronal and glial function. Recent experimental evidence suggests that disturbance by HIV-1 results not only in neuronal injury and death but also in impairment of neurogenesis. This article will review recently identified pathological mechanisms which potentially contribute to the development of neurocognitive impairment and dementia in association with HIV-1 infection.

Entities:  

Mesh:

Year:  2008        PMID: 17981728      PMCID: PMC3432272          DOI: 10.2741/2860

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  116 in total

1.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.

Authors:  Q Ma; D Jones; P R Borghesani; R A Segal; T Nagasawa; T Kishimoto; R T Bronson; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

2.  Treating AIDS dementia.

Authors:  S A Lipton
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

3.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

Review 4.  Cell death in HIV dementia.

Authors:  M P Mattson; N J Haughey; A Nath
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

Review 5.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

6.  HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system.

Authors:  U Koedel; B Kohleisen; B Sporer; F Lahrtz; V Ovod; A Fontana; V Erfle; H W Pfister
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

7.  Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons.

Authors:  G Fontana; L Valenti; M Raiteri
Journal:  J Neurosci Res       Date:  1997-09-15       Impact factor: 4.164

8.  Measurement of CNS HIV burden and its association with neurologic damage.

Authors:  C A Wiley; E Masliah; C L Achim
Journal:  Adv Neuroimmunol       Date:  1994

Review 9.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.

Authors:  Tsvee Lapidot; Isabelle Petit
Journal:  Exp Hematol       Date:  2002-09       Impact factor: 3.084

10.  Brain viral burden in HIV infection.

Authors:  C L Achim; R Wang; D K Miners; C A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  1994-05       Impact factor: 3.685

View more
  48 in total

Review 1.  Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury.

Authors:  Ricky Maung; Kathryn E Medders; Natalia E Sejbuk; Maya K Desai; Rossella Russo; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

Review 2.  Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.

Authors:  Kathryn E Medders; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-01       Impact factor: 4.147

3.  Neuroprotective activity of pDING in response to HIV-1 Tat.

Authors:  Nune Darbinian; Kamel Khalili; Shohreh Amini
Journal:  J Cell Physiol       Date:  2014-02       Impact factor: 6.384

4.  Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

Authors:  Ruma Mukerjee; J Robert Chang; Luis Del Valle; Asen Bagashev; Monika M Gayed; Randolph B Lyde; Brian J Hawkins; Eugen Brailoiu; Eric Cohen; Chris Power; S Ausim Azizi; Benjamin B Gelman; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 5.  Innate immune responses to HIV infection in the central nervous system.

Authors:  Rebeca Geffin; Micheline McCarthy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 6.  Targeting anti-HIV drugs to the CNS.

Authors:  Kavitha S Rao; Anuja Ghorpade; Vinod Labhasetwar
Journal:  Expert Opin Drug Deliv       Date:  2009-08       Impact factor: 6.648

Review 7.  Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?

Authors:  Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke
Journal:  ACS Chem Neurosci       Date:  2015-06-19       Impact factor: 4.418

8.  Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction.

Authors:  Michael Ditiatkovski; Nigora Mukhamedova; Dragana Dragoljevic; Anh Hoang; Hann Low; Tatiana Pushkarsky; Ying Fu; Irena Carmichael; Andrew F Hill; Andrew J Murphy; Michael Bukrinsky; Dmitri Sviridov
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

9.  NFκB signaling regulates embryonic and adult neurogenesis.

Authors:  Yonggang Zhang; Wenhui Hu
Journal:  Front Biol (Beijing)       Date:  2012-08

10.  Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND).

Authors:  Calixto-Hope Lucas; Mathilde Calvez; Roshni Babu; Amanda Brown
Journal:  Neurosci Lett       Date:  2013-11-08       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.